Previous Article | Next Article 
Infection and Immunity, March 2001, p. 1433-1439, Vol. 69, No. 3
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.3.1433-1439.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Mycobacterium tuberculosis 19-Kilodalton
Lipoprotein Inhibits Mycobacterium smegmatis-Induced
Cytokine Production by Human Macrophages In Vitro
Frank A.
Post,1,2,
Claudia
Manca,2
Olivier
Neyrolles,3
Bernhard
Ryffel,1
Douglas B.
Young,3 and
Gilla
Kaplan2,*
Department of Immunology, University of Cape
Town Medical School, Observatory 7925, Cape Town, South
Africa1; Laboratory of Cellular
Physiology and Immunology, The Rockefeller University, New York, New
York 100212; and Department of
Infectious Diseases and Microbiology, Imperial College School of
Medicine, London W2 1PG, United Kingdom3
Received 19 October 2000/Returned for modification 15 November
2000/Accepted 27 November 2000
Vaccination of mice with Mycobacterium vaccae or
M. smegmatis induces some protection against M. tuberculosis challenge. The 19-kDa lipoprotein of M. tuberculosis, expressed in M. vaccae or M. smegmatis (M. smeg19kDa), abrogates this protective
immunity. To investigate the mechanism of this suppression of immunity, human monocyte-derived macrophages (MDM) were infected with M. smeg19kDa. Infection resulted in reduced production of tumor
necrosis factor alpha (TNF-
) (P < 0.01),
interleukin-12 (IL-12) (P < 0.05), IL-6
(P < 0.05), and IL-10 (P < 0.05),
compared to infection with M. smegmatis vector (M. smegV). Infection with M. smeg19kDa and with M. smegV had no differential effect on expression of costimulatory molecules on MDM, nor did it affect the proliferation of presensitized T cells cocultured with infected MDM. When MDM were infected with M. smegmatis expressing mutated forms of the 19-kDa
lipoprotein, including non-O-glycosylated (M. smeg19NOG),
nonsecreted (M. smeg19NS), and nonacylated (M. smeg19NA) variants, the reduced production of TNF-
or IL-12
was not observed. When the purified 19-kDa lipoprotein was added
directly to cultures of infected monocytes, there was little effect on
either induction of cytokine production or its inhibition. Thus, the
immunosuppressive effect is dependent on glycosylated and acylated
19-kDa lipoprotein present in the phagosome containing the
mycobacterium. These results suggest that the diminished protection
against challenge with M. tuberculosis seen in mice vaccinated with M. smegmatis expressing the 19-kDa
lipoprotein is the result of reduced TNF-
and IL-12 production,
possibly leading to reduced induction of T-cell activation.
*
Corresponding author. Mailing address: Laboratory of
Cellular Physiology and Immunology, The Rockefeller University, 1230 York Ave., New York, NY 10021. Phone: (212) 327-8375. Fax: (212) 327-8875. E-mail: kaplang{at}rockvax.rockefeller.edu.

Present address: Infectious Diseases Clinical Research Unit, The
Lung Institute, University of Cape Town, Cape Town, South
Africa.
Infection and Immunity, March 2001, p. 1433-1439, Vol. 69, No. 3
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.3.1433-1439.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Nair, S., Ramaswamy, P. A., Ghosh, S., Joshi, D. C., Pathak, N., Siddiqui, I., Sharma, P., Hasnain, S. E., Mande, S. C., Mukhopadhyay, S.
(2009). The PPE18 of Mycobacterium tuberculosis Interacts with TLR2 and Activates IL-10 Induction in Macrophage. J. Immunol.
183: 6269-6281
[Abstract]
[Full Text]
-
Lun, S., Bishai, W. R.
(2007). Characterization of a Novel Cell Wall-anchored Protein with Carboxylesterase Activity Required for Virulence in Mycobacterium tuberculosis. J. Biol. Chem.
282: 18348-18356
[Abstract]
[Full Text]
-
Yu, J.-S., Peacock, J. W., Vanleeuwen, S., Hsu, T., Jacobs, W. R. Jr., Cayabyab, M. J., Letvin, N. L., Frothingham, R., Staats, H. F., Liao, H.-X., Haynes, B. F.
(2006). Generation of Mucosal Anti-Human Immunodeficiency Virus Type 1 T-Cell Responses by Recombinant Mycobacterium smegmatis{triangledown}. CVI
13: 1204-1211
[Abstract]
[Full Text]
-
Stewart, G. R., Wilkinson, K. A., Newton, S. M., Sullivan, S. M., Neyrolles, O., Wain, J. R., Patel, J., Pool, K.-L., Young, D. B., Wilkinson, R. J.
(2005). Effect of Deletion or Overexpression of the 19-Kilodalton Lipoprotein Rv3763 on the Innate Response to Mycobacterium tuberculosis. Infect. Immun.
73: 6831-6837
[Abstract]
[Full Text]
-
Turner, J., Dobos, K. M., Keen, M. A, Frank, A. A., Ehlers, S., Orme, I. M., Belisle, J. T., Cooper, A. M.
(2004). A Limited Antigen-Specific Cellular Response Is Sufficient for the Early Control of Mycobacterium tuberculosis in the Lung but Is Insufficient for Long-Term Survival. Infect. Immun.
72: 3759-3768
[Abstract]
[Full Text]
-
Dahl, J. L., Kraus, C. N., Boshoff, H. I. M., Doan, B., Foley, K., Avarbock, D., Kaplan, G., Mizrahi, V., Rubin, H., Barry, C. E. III
(2003). The role of RelMtb-mediated adaptation to stationary phase in long-term persistence of Mycobacterium tuberculosis in mice. Proc. Natl. Acad. Sci. USA
100: 10026-10031
[Abstract]
[Full Text]
-
Gehring, A. J., Rojas, R. E., Canaday, D. H., Lakey, D. L., Harding, C. V., Boom, W. H.
(2003). The Mycobacterium tuberculosis 19-Kilodalton Lipoprotein Inhibits Gamma Interferon-Regulated HLA-DR and Fc{gamma}R1 on Human Macrophages through Toll-Like Receptor 2. Infect. Immun.
71: 4487-4497
[Abstract]
[Full Text]
-
Smith, I.
(2003). Mycobacterium tuberculosis Pathogenesis and Molecular Determinants of Virulence. Clin. Microbiol. Rev.
16: 463-496
[Abstract]
[Full Text]
-
Ulrichs, T., Moody, D. B., Grant, E., Kaufmann, S. H. E., Porcelli, S. A.
(2003). T-Cell Responses to CD1-Presented Lipid Antigens in Humans with Mycobacterium tuberculosis Infection. Infect. Immun.
71: 3076-3087
[Abstract]
[Full Text]
-
Basso, H., Rharbaoui, F., Staendner, L. H., Medina, E., Garcia-Del Portillo, F., Guzman, C. A.
(2002). Characterization of a Novel Intracellularly Activated Gene from Salmonella enterica Serovar Typhi. Infect. Immun.
70: 5404-5411
[Abstract]
[Full Text]
-
Yamada, H., Mizuno, S., Reza-Gholizadeh, M., Sugawara, I.
(2001). Relative Importance of NF-kappa B p50 in Mycobacterial Infection. Infect. Immun.
69: 7100-7105
[Abstract]
[Full Text]
-
Nau, G. J., Richmond, J. F. L., Schlesinger, A., Jennings, E. G., Lander, E. S., Young, R. A.
(2002). Human macrophage activation programs induced by bacterial pathogens. Proc. Natl. Acad. Sci. USA
99: 1503-1508
[Abstract]
[Full Text]